MML Investors Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.2M Buy
70,299
+6,873
+11% +$2.55M 0.06% 326
2026
Q1
$18.6M Sell
63,426
-9,891
-13% -$3.25M 0.05% 352
2025
Q4
$25.7M Sell
73,317
-3,083
-4% -$1.04M 0.06% 295
2025
Q3
$24.7M Sell
76,400
-3,551
-4% -$1.1M 0.07% 284
2025
Q2
$31.1M Sell
79,951
-3,048
-4% -$1.23M 0.09% 218
2025
Q1
$36.1M Buy
82,999
+8,643
+12% +$3.47M 0.12% 179
2024
Q4
$27.4M Buy
74,356
+10,527
+16% +$4.41M 0.09% 215
2024
Q3
$33.2M Buy
63,829
+2,172
+4% +$1.16M 0.12% 180
2024
Q2
$33.4M Sell
61,657
-8,365
-12% -$4.42M 0.14% 166
2024
Q1
$36.3M Buy
70,022
+3,039
+5% +$1.51M 0.15% 154
2023
Q4
$31.6M Buy
66,983
+12,828
+24% +$5.93M 0.15% 161
2023
Q3
$23.6M Buy
54,155
+7,063
+15% +$3.2M 0.13% 175
2023
Q2
$20.9M Buy
+47,092
New +$21.7M 0.12% 196
2023
Q1
Sell
-42,295
Closed -$21.7M 2133
2022
Q4
$21.7M Buy
42,295
+4,823
+13% +$2.45M 0.14% 160
2022
Q3
$17M Sell
37,472
-1,114
-3% -$533K 0.13% 177
2022
Q2
$18.6M Buy
38,586
+2,780
+8% +$1.38M 0.14% 166
2022
Q1
$17.6M Buy
35,806
+4,182
+13% +$1.91M 0.12% 187
2021
Q4
$14.7M Buy
31,624
+2,233
+8% +$939K 0.11% 208
2021
Q3
$11M Buy
29,391
+3,521
+14% +$1.34M 0.09% 254
2021
Q2
$9.88M Buy
25,870
+2,246
+10% +$858K 0.08% 257
2021
Q1
$8.48M Buy
23,624
+1,587
+7% +$510K 0.08% 252
2020
Q4
$7.08M Buy
22,037
+791
+4% +$243K 0.08% 255
2020
Q3
$5.71M Buy
21,246
+1,360
+7% +$366K 0.07% 254
2020
Q2
$5.23M Buy
19,886
+343
+2% +$91.5K 0.07% 256
2020
Q1
$4.44M Buy
19,543
+1,166
+6% +$318K 0.08% 242
2019
Q4
$5.55M Sell
18,377
-954
-5% -$263K 0.08% 244
2019
Q3
$4.64M Sell
19,331
-1,929
-9% -$529K 0.07% 251
2019
Q2
$6M Buy
21,260
+4,947
+30% +$1.35M 0.09% 234
2019
Q1
$4.68M Buy
16,313
+4,231
+35% +$1.22M 0.07% 260
2018
Q4
$3.17M Buy
12,082
+297
+3% +$81.7K 0.06% 311
2018
Q3
$3.23M Buy
11,785
+2,990
+34% +$776K 0.05% 310
2018
Q2
$2.09M Buy
8,795
+1,233
+16% +$286K 0.05% 339
2018
Q1
$1.66M Buy
7,562
+2,250
+42% +$529K 0.04% 394
2017
Q4
$1.2M Buy
5,312
+1,992
+60% +$424K 0.02% 483
2017
Q3
$630K Buy
3,320
+363
+12% +$69.1K 0.01% 685
2017
Q2
$556K Buy
2,957
+220
+8% +$39.5K 0.01% 725
2017
Q1
$453K Buy
+2,737
New +$435K 0.01% 470

Other funds holding ELV

MML Investors Services's ELV Position: Q2 2026 in Review

MML Investors Services increased its Elevance Health (ELV) stake by 11% in Q2 2026, buying an estimated $2.55M and bringing the position to 70,299 shares worth $27.2M. The position accounts for 0.06% of the portfolio, ranked #326.

MML Investors Services first reported a position in ELV in Q1 2017 and has held it in 37 quarters since. The position peaked at $36.3M in Q1 2024. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • MML Investors Services held 70,299 shares of Elevance Health worth $27.2M as of Q2 2026.
  • MML Investors Services bought 6,873 Elevance Health shares in Q2 2026, an estimated $2.55M.
  • Elevance Health made up 0.06% of MML Investors Services's portfolio in Q2 2026, its #326 holding.
  • MML Investors Services first reported a position in Elevance Health in Q1 2017 and has held it in 37 quarters since.
  • MML Investors Services's Elevance Health position peaked at $36.3M in Q1 2024.
  • 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.